The abstract is read at the publisher; the summary is JClub's.
Nanoparticle-enabled gene delivery is positioned as a promising approach for pediatric brain tumors by enabling blood-brain barrier penetration and tumor-specific uptake.
- Why it matters: Pediatric brain tumors are the leading cause of disease-related death in children, and effective therapies are limited by BBB crossing and frequent recurrence from genetic/epigenetic changes and treatment resistance.
- What they did: This review evaluates genetic engineering strategies and nanoparticle-based delivery systems, focusing on design principles, delivery mechanisms, and therapeutic approaches in preclinical and clinical investigations.
- The result: The synthesis highlights major challenges and future directions for nanoparticle-mediated gene therapy, supporting its potential to reshape treatment paradigms and improve outcomes and quality of life for children.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.